Drugs / sofadil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04453800 | Oct 2016 → Jan 2018 | ischemic stroke | Peking University Third Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sofadil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04453800 ↗ |
| Known as | Neu2000KW | “Drug: sofadil【Neu2000KW】” NCT04453800 ↗ |
| Action | Inhibit | “moderate NMDA receptor antagonism” NCT04453800 ↗ |
| Route | Intravenous | “Intravenous infusion of sofadil” NCT04453800 ↗ |